Related Experiment Video
Updated: Oct 10, 2025

06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
7.6K
Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method.
Theodore Arsenault1, Collin M Labak2, Kevin Chaung1
1Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, USA.
Cureus
|December 8, 2021
Summary
Surgical resection with intracranial brachytherapy is an option for recurrent brain metastases. This case study explores GammaTile (GT), a cesium-131 brachytherapy device, and its dosimetric modeling for patient treatment.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Medical Physics
Background:
- Recurrent brain metastases pose a significant clinical challenge, often requiring multimodal treatment strategies.
- Surgical resection combined with intracranial brachytherapy is an established option for managing these lesions.
- Cesium-131 (131Cs) based brachytherapy offers a unique radiobiological profile for targeted radiation delivery.
Observation:
- This report details a case of recurrent brain metastases treated with GammaTile (GT), a novel brachytherapy device.
- The GammaTile device utilizes 131Cs seeds embedded in a collagen carrier, designed for targeted intraoperative radiation therapy.
- The case involved a patient with previously treated brain metastases who experienced recurrence.
Findings:
- The study demonstrates the successful application of GammaTile for treating recurrent brain metastases.
- A key contribution is the presentation of a dosimetric modeling method specific to the GammaTile device.
- Dosimetric analysis is crucial for optimizing radiation dose distribution and treatment efficacy.
Implications:
- This case highlights the potential of GammaTile as a treatment option for recurrent brain metastases.
- The developed dosimetric modeling method can aid clinicians in planning and delivering precise radiation doses.
- Further research and clinical studies are warranted to establish the long-term efficacy and safety of this approach.

